Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.01
Delayed Data
As of Jul 22
 -0.15 / -2.44%
Today’s Change
3.61
Today|||52-Week Range
11.15
-1.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues1.9M1.4M5.1M2.5M
 
 
 
 
 
Cost of Goods Sold178.0K123.0K----
 
 
 
Depreciation And Amortization129.0K137.0K167.0K751.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.6M1.1M----
 
 
 
General Expenses12.5M11.4M11.5M14.2M
 
 
 
 
 
Research And Development6.5M6.9M7.9M9.1M
 
 
 
 
 
Total Operating Expenses12.8M11.6M11.7M15.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.9M-10.2M-6.6M-12.5M
 
 
 
 
 
Extraordinary Credit0.00200.0K--0.00
 
 
Extraordinary Charge-800.0K0.00-700.0K-200.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.7M-10.0M-7.3M-12.7M
 
 
 
 
 
Income Taxes0.000.00-133.0K0.00
 
 
Minority Interest0.000.00-7.0K-18.0K
 
 
 
Net Income-11.7M-10.0M-7.1M-12.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.6M69.7M69.9M69.9M
 
 
 
 
 
Shares To Calculate EPS Diluted69.6M69.7M69.9M69.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.14-$0.10-$0.18
 
 
 
 
 
EPS Diluted-$0.17-$0.14-$0.10-$0.18